This site is intended for healthcare professionals only
LoginRegister
India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told20 lakh tablets seized in biggest pharma drug haul in Lucknow
Lupin rolls out Loteprednol Etabonate Ophthalmic Suspension in USLupin rolls out Loteprednol Etabonate Ophthalmic Suspension, 0.5% in US
GSK blood cancer drug Blenrep faces USFDA scrutiny over vision issuesGSK blood cancer drug Blenrep faces USFDA scrutiny over vision issues
Expert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, XenograftsExpert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, Xenografts
Phase 2b trial of RopanicantFirst patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life...
Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopeniaSanofi intravitreal gene therapy wins USFDA fast track designation for geographic atrophy due to...
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAShilpa Medicare Dabaspet unit gets VAI classification from USFDA
Biocon inaugurates first US manufacturing facility in New JerseyBiocon Biologics expands biosimilar insulin portfolio with USFDA nod of Kirsty
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy licenseBoehringer Ingelheim, LEO Pharma collaborate to commercialize, further develop Spevigo
No Eligible Successor: Centre Clarifies DCGIs Contractual ReappointmentNo Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialCDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial
X